CAMPCamp4 Therapeutics Corpvs its industry peers
A metric-by-metric comparison of Camp4 Therapeutics Corp against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAMPEsta | $259M#5 | — | — | 73.9x#4 | 436.5%#1 | -55.2%#6 | -1502.4%#4 | — | — | — | 58.8%#2 | — |
| CTNM | $302M#1 | — | 1.3x#2 | — | -100.0%#7 | -41.9%#5 | — | -25.0%#1 | — | — | 5.5%#4 | — |
| UPB | $290M#2 | — | 1.1x#1 | 101.7x#5 | 20.4%#4 | -128.4%#8 | -5618.8%#5 | -52.9%#2 | — | — | -66.9%#5 | — |
| PYXS | $279M#3 | — | 24.4x#4 | 20.2x#3 | -14.2%#5 | -3.0%#4 | -609.2%#3 | -696.0%#4 | — | — | 51.6%#3 | — |
| CUE | $260M#4 | — | 112.3x#5 | 9.4x#2 | 195.7%#2 | 34.6%#1 | -96.7%#1 | -1151.6%#5 | — | — | — | — |
| FHTX | $249M#6 | — | — | 8.1x#1 | 36.8%#3 | 14.2%#3 | -279.5%#2 | — | — | — | — | — |
| ALXO | $241M#8 | — | 1.8x#3 | — | — | 24.6%#2 | — | -74.7%#3 | -84.4%#1 | — | 64.2%#1 | — |
| RNAC | $242M#7 | — | — | 605.5x#6 | -99.0%#6 | -68.3%#7 | -35851.3%#6 | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice